SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study - Archive ouverte HAL Access content directly
Conference Papers Year : 2017

SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study

F. Maurice
  • Function : Author
P. Ancel
  • Function : Author
E. Mayoux
  • Function : Author
I. Abdesselam
  • Function : Author
F. Kober
Centre de résonance magnétique biologique et médicale
P. Darmon
  • Function : Author
M. Grino
  • Function : Author
B. Gaborit
  • Function : Author
Centre de résonance magnétique biologique et médicale
Monique Bernard
Centre de résonance magnétique biologique et médicale
CV
A. Dutour
  • Function : Author

Domains

Computer Science [cs] Medical Imaging Life Sciences [q-bio] Bioengineering Imaging

Monique BERNARD  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-01784725

Submitted on : Thursday, May 3, 2018-4:57:09 PM

Last modification on : Friday, March 24, 2023-2:53:07 PM

Not file

Dates and versions

hal-01784725 , version 1 (03-05-2018)

Identifiers

  • HAL Id : hal-01784725 , version 1

Cite

F. Maurice, P. Ancel, E. Mayoux, I. Abdesselam, F. Kober, et al.. SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study. 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), EASD, Sep 2017, Lisbon, Portugal. pp.S414--S414. ⟨hal-01784725⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRMBM
20 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More